
In an interview with Pharmacy Times, Thomas Hope, MD, explains how earlier consideration of peptide receptor radionuclide therapy in neuroendocrine tumors makes treatment scheduling and continuity of care essential opportunities for pharmacists.
Top news of the week from Specialty Pharmacy Times.
[<a href="//storify.com/pharmacytimes/hiv-treatment-advances-highlight-spt-week-in-revie" target="_blank">View the story "HIV Treatment Advances Highlight SPT Week in Review" on Storify</a>]





